Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LNCRNA expression in pancreatic cancer tissues

ABSTRACT: LNCRNA plays an important role in the development of pancreatic cancer, and in order to investigate the biological function of LNCRNA in pancreatic cancer, we have measured its expression

ORGANISM(S): Homo sapiens

PROVIDER: GSE278515 | GEO | 2024/10/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

LNCRNA expression in pancreatic cancer tissues

Project description:LNCRNA expression in pancreatic cancer tissues

| PRJNA1167679 | ENA

lncRNA profile of CAFs isolated from Pancreatic cancer

Project description:Perineural invasion (PNI) is a unique biological feature of pancreatic cancer and is a key cause of pancreatic cancer metastasis, recurrence and poor postoperative survival, but its mechanism is largely unclarified. Clinical sample analysis and endoscopic ultrasonographic elasticity scoring indicated that cancer-associated fibroblasts (CAFs) are closely related to the occurrence of PNI. Furthermore, CAF-derived extracellular vesicles played an extremely important role in PNI in a dorsal root ganglion (DRG) coculture model and sciatic nerve model. To explore the lncRNA packaged in CAFs EVs, we conducted the lncRNA profile of CAFs isolated from pancreatic cancer

2024-04-20 | GSE264223 | GEO

Development of lncRNA and Mrna expression signatures for pancreatic ductal adenocarcinoma

Project description:To further development of our lncRNA and mRNA expression approach to pancreatic ductal adenocarcinoma(PDAC), we have employed lncRNA and mRNA microarray expression profiling as a discovery platform to identify lncRNA and mRNA expression in pancreatic ductal adenocarcinoma.Human pancreatic ductal adenocarcinoma tissues and normal pancreatic tissues from PDAC donors and other duodenum diseases donors. analyze mRNA and lncRNA expression in pancreatic ductal adenocarcinoma (PDAC) by microarray platform

2014-11-18 | E-GEOD-57144 | biostudies-arrayexpress

Gene expression of endothelial cells isolated from pancreatic cancer tissues and from chronic pancreatitis tissues

Project description:Endothelial cells existed in the cancer tissue have unique biological characteristics that are different from those found in the noncancerous tissue of the same organ. In order to investigate molecular mechanisms involved in the unique biological phenotypes of endothelial cells in the cancer tissue, we compared gene expression profiles of endothelial cells isolated from pancreatic cancer tissues with those from chronic pancreatitis tissues.

2020-11-10 | GSE151945 | GEO

Global mRNA/LncRNA expression analysis of pancreatic tumors causing type3C Diabetes Mellitus

Project description:Pancreatic tumors with small size can cause type3C Diabetes Mellitus (PCA-DM) but the mechanism is unknown. In this study we aimed at revealing the mRNA and long noncoding RNA (LncRNA) expression patterns of pancreatic tumors that triggered PCA-DM. Four pancreatic tumors from patients with PCA-DM (A1-A4), four pancreatic tumors from patients without PCA-DM (B1-B4), and four pancreatic tissues from patients with pancreatitis were individually profiled with Agilent microarrays(Arraystar Human LncRNA Array v3.0). Pancreatic tumors with PCA-DM or without PCA-DM, and pancreatic tissues of pancreatitis were individually profiled.

2014-09-06 | E-GEOD-61166 | biostudies-arrayexpress

RNA-sequencing of human pancreatic adenocarcinoma cancer tissues

Project description:RNA-seq profiling was conducted on clinically-annotated human pancreatic adenocarcinoma cancer tissues We measured the transcriptome in 51 clinically-annotated human pancreatic adenocarcinoma cancer tissues

2016-06-11 | E-GEOD-79668 | biostudies-arrayexpress

LncRNA and mRNA expression profiles of 3 prostate cancer tumor tissues and 3 normal prostate tissues

Project description:LncRNA and mRNA expression profiles of 3 prostate cancer tumor samples and 3 normal prostate samples were measured by microarray

2017-06-12 | GSE73397 | GEO

lncRNA profile of CAFs isolated from Pancreatic cancer

Project description:lncRNA profile of CAFs isolated from Pancreatic cancer

| PRJNA1101497 | ENA

SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing in promotion of pancreatic cancer resistance to gemcitabine I

Project description:Serine/arginine-rich splicing factor 3 (SRSF3) functions to regulate mRNA alternative splicing, a molecular mechanism to process more than 90% of the protein-coding genes and provides an essential source for the biological versatility and targeting of SRSF3 could be a novel approach for cancer therapy. This study identify that SRSF3 expression was upregulated in pancreatic cancer tissues and associated with drug resistance and poor prognosis. Thus, we found that SRSF3 regulated ANRIL splicing and modified m6A modification of ANRIL in pancreatic cancer cells. More importantly, we demonstrated that the m6A methylation on lncRNA-ANRIL was essential for splicing process. Meanwhile, we also found that the different isoforms of ANRIL were differentially expressed in drug-resistant pancreatic cancer cell lines, and SRSF3 promotes gemcitabine resistance by regulating the expression of ANRIL-208. In addition, ANRIL-208 regulated pancreatic cancer cell chemoresistance by forming a complex with Ring1b and EZH2 and enhanced DNA homologous recombination repair (HR) capacity. In conclusion, the current study first established the link among SRSF3, m6A modification, lncRNA splicing, and DNA HR repair in pancreatic cancer, and first demonstrated that abnormal alternative splicing and m6A modification are closely related to chemotherapy resistance in pancreatic cancer.

2022-05-11 | GSE197352 | GEO

SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing in promotion of pancreatic cancer resistance to gemcitabine II

2022-05-11 | GSE197532 | GEO